Your browser doesn't support javascript.
loading
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study.
Brink, Mirian; Kahle, Xaver U; Vermaat, Joost S P; Zijlstra, Josee M; Chamuleau, Martine; Kersten, Marie José; Durmaz, Müjde; Plattel, Wouter J; Lugtenburg, Pieternella J; Stevens, Wendy; Mous, Rogier; de Vries, Elisabeth G E; van der Poel, Marjolein W M; Panday, Prashant V Nannan; Huls, Gerwin; van Meerten, Tom; Nijland, Marcel.
Afiliação
  • Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Kahle XU; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Zijlstra JM; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Chamuleau M; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Kersten MJ; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Durmaz M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Stevens W; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • van der Poel MWM; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands; and.
  • Panday PVN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
  • Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Blood Adv ; 5(15): 2958-2964, 2021 08 10.
Article em En | MEDLINE | ID: mdl-34338755
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Medicamentos Biossimilares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Medicamentos Biossimilares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda